These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21037121)

  • 21. Clinical differences in patients with Alzheimer's disease according to the presence or absence of anosognosia: implications for perceived quality of life.
    Conde-Sala JL; Reñé-Ramírez R; Turró-Garriga O; Gascón-Bayarri J; Juncadella-Puig M; Moreno-Cordón L; Viñas-Diez V; Garre-Olmo J
    J Alzheimers Dis; 2013; 33(4):1105-16. PubMed ID: 23128559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.
    Turró-Garriga O; Garre-Olmo J; Calvó-Perxas L; Reñé-Ramírez R; Gascón-Bayarri J; Conde-Sala JL
    J Alzheimers Dis; 2016; 51(2):357-66. PubMed ID: 26890611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of Cognitive Anosognosia and its Variation with the Severity of Dementia in Patients with Alzheimer's Disease.
    Avondino E; Antoine P
    J Alzheimers Dis; 2016; 50(1):89-99. PubMed ID: 26638866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between anosognosia and regional cerebral blood flow in Alzheimer's disease.
    Shibata K; Narumoto J; Kitabayashi Y; Ushijima Y; Fukui K
    Neurosci Lett; 2008 Apr; 435(1):7-10. PubMed ID: 18353553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anosognosia and Alzheimer's disease: the role of depressive symptoms in mediating impaired insight.
    Smith CA; Henderson VW; McCleary CA; Murdock GA; Buckwalter JG
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):437-44. PubMed ID: 10923053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription.
    Benoit M; Andrieu S; Lechowski L; Gillette-Guyonnet S; Robert PH; Vellas B;
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):409-14. PubMed ID: 17918770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognition and psychopathology in nonagenarians and centenarians living in geriatric nursing homes in Switzerland: a focus on anosognosia.
    Mall JF; Chouiter L; Antonietti JP; Ebbing K; von Gunten A
    Psychogeriatrics; 2014 Mar; 14(1):55-62. PubMed ID: 24528775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight and danger in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Adrian J; Robinson RG
    Eur J Neurol; 2007 Apr; 14(4):455-60. PubMed ID: 17388998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anosognosia in Alzheimer's disease: the role of impairment levels in assessment of insight across domains.
    Leicht H; Berwig M; Gertz HJ
    J Int Neuropsychol Soc; 2010 May; 16(3):463-73. PubMed ID: 20188013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective longitudinal study of depression and anosognosia in Alzheimer's disease.
    Starkstein SE; Chemerinski E; Sabe L; Kuzis G; Petracca G; Tesón A; Leiguarda R
    Br J Psychiatry; 1997 Jul; 171():47-52. PubMed ID: 9328494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross domain self-monitoring in anosognosia for memory loss in Alzheimer's disease.
    Chapman S; Colvin LE; Vuorre M; Cocchini G; Metcalfe J; Huey ED; Cosentino S
    Cortex; 2018 Apr; 101():221-233. PubMed ID: 29518705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective longitudinal study of apathy in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Robinson RG
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):8-11. PubMed ID: 16361584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anosognosia in patients with Alzheimer's disease: current perspectives.
    Tagai K; Nagata T; Shinagawa S; Shigeta M
    Psychogeriatrics; 2020 May; 20(3):345-352. PubMed ID: 31930617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methods for assessing impaired insight in Alzheimer's disease--a critical review].
    Leicht H; Gertz HJ
    Psychiatr Prax; 2009 Mar; 36(2):58-66. PubMed ID: 18726844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severity of dementia, anosognosia, and depression in relation to the quality of life of patients with Alzheimer disease: discrepancies between patients and caregivers.
    Conde-Sala JL; Reñé-Ramírez R; Turró-Garriga O; Gascón-Bayarri J; Campdelacreu-Fumadó J; Juncadella-Puig M; Rico-Pons I; Garre-Olmo J
    Am J Geriatr Psychiatry; 2014 Feb; 22(2):138-47. PubMed ID: 23567444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.
    Palmer K; Di Iulio F; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Spalletta G
    J Alzheimers Dis; 2010; 20(1):175-83. PubMed ID: 20164594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and secondary anosognosia for memory impairment in patients with Alzheimer's disease.
    Hannesdottir K; Morris RG
    Cortex; 2007 Oct; 43(7):1020-30. PubMed ID: 17941357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mood-congruent recollection and anosognosia in Alzheimer's disease.
    Bertrand E; Dourado MC; Laks J; Morris RG; Landeira-Fernandez J; Mograbi DC
    Cortex; 2016 Nov; 84():55-62. PubMed ID: 27697664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mnemonic anosognosia in Alzheimer's disease: a test of Agnew and Morris (1998).
    Ansell EL; Bucks RS
    Neuropsychologia; 2006; 44(7):1095-102. PubMed ID: 16324727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.